Orientation and Factual Memory -Auditory Attention and Memory- Visual Perception Visual Attention and Memory
Assess attention, memory, executive functions, language, and visuospatial skills.
Monitor intervals in recovery, assess driving readiness, measure language competency, and for research of adults with multiple types of neurological impact.
Clearer interpretation for people with aphasia.
Use for patients of all severity levels.
Effective tool for English or Spanish-speaking adults with known or suspected neurological impairment as a result of stroke, traumatic brain injury, or dementia.
CLQT+ offers two standard administration paths: Traditional Administration and Aphasia Administration.
Raven's 2 provides a measure of clear-thinking ability and intellectual capacity that minimizes the impacts of language skills and cultural differences.
Provides a standard score as well as a percentile rank.
Can be administered fairly to virtually everyone, including those who are not language proficient or have communication-related disabilities.
Digital test forms are constructed from item bank to limit item overlap between test takers, for greater security and limitation of practice effects.
TONI-4 offers an assessment of intelligence, aptitude, abstract reasoning, and problem solving. It features new norms to help ensure proper representation of demographic changes in the U.S. population.
Provides two equivalent forms, each containing 60 items arranged in easy to difficult order.
Educational, cultural, or experiential backgrounds do not adversely affect test results.
Pragmatic administration and response format. Simple oral instructions only require test-takers to answer with meaningful gestures such as pointing, nodding, or blinking.
Measure executive function in children and adolescents ages 5–18 years with the parent and teacher forms and ages 11–18 years with the self-report form. With adults clients ages 18–90 years, administer the informant and self-report forms.
Although RBANS Update was originally developed with a primary focus on assessment of dementia, special group studies are available for Alzheimer’s Disease, Vascular Dementia, HIV Dementia, Huntington’s Disease, Parkinson’s Disease, Depression, Schizophrenia, and Closed Head Injury. RBANS also has utility as a screener for neurocognitive status in younger patients.
Benefits
Covers five domains: Immediate Memory, Visuospatial/Constructional, Language, Attention, and Delayed Memory.
Screen for deficits in acute-care setting and neurocognitive status in adolescents.
Track recovery during rehabilitation and progression of neurological disorders.
Use as a stand-alone “core” battery for the detection and characterization of dementia in the elderly
Use as a neuropsychological “screen battery” when lengthier standardization assessments are either impractical or inappropriate
Repeat evaluations when an alternate form is needed to control for content practice effects.
Identify inclusion/exclusion criteria as well as efficacy and cognitive side effects in Clinical Trials.